Nicholas Charles Lazzara

Title: Innovations by Nicholas Charles Lazzara

Introduction

Nicholas Charles Lazzara is a notable inventor based in Denver, CO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cancer. With a total of 2 patents, Lazzara's work focuses on innovative solutions for abnormal cell growth.

Latest Patents

Lazzara's latest patents include inventions related to HER2 mutation inhibitors. This invention pertains to compounds of Formula (I) and their enantiomers, as well as pharmaceutically acceptable salts of these compounds. The invention also encompasses pharmaceutical compositions that include such compounds and salts, along with methods for their use in treating abnormal cell growth, including cancer. Another significant patent involves substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors, which similarly relates to compounds of Formula (I) and their enantiomers, aimed at providing therapeutic solutions for cancer treatment.

Career Highlights

Throughout his career, Lazzara has worked with prominent companies in the pharmaceutical industry, including Array Biopharma Inc. and Pfizer Corporation. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Lazzara has collaborated with notable professionals in his field, including Ellen Ruth Laird and Bradley Jon Newhouse. These collaborations have likely enhanced his research and development efforts.

Conclusion

Nicholas Charles Lazzara's contributions to pharmaceutical innovations, particularly in cancer treatment, highlight his role as a significant inventor in the industry. His patents reflect a commitment to advancing medical science and improving patient outcomes.